Effectiveness of Carbon Ion Radiotherapy for Gynecological Melanomas
Author Information
Author(s): Barcellini Amelia, Fontana Giulia, Vai Alessandro, Aletti Giovanni Damiano, Charalampopoulou Alexandra, Chiellino Silvia, Ditto Antonino, Landoni Fabio, Locati Laura Deborah, Mangili Giorgia, Martinelli Fabio, Piccolo Federica, Franzetti Jessica, Imparato Sara, Raspagliesi Francesco, Orlandi Ester, Strojan Primož, Gabrielli Brian
Primary Institution: National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy
Hypothesis
The study aims to assess the effectiveness and tolerability of carbon ion radiotherapy (CIRT) in patients with inoperable gynecological mucosal melanoma.
Conclusion
CIRT was found to be effective and safe for treating gynecological melanomas, with high local control rates and manageable toxicity.
Supporting Evidence
- 11 patients underwent pelvic CIRT for mucosal malignant melanoma.
- The objective response rate (ORR) was 82% and clinical benefit (CB) was 100%.
- Local control rates at 1 and 2 years were 100% and 86%, respectively.
- The treatment was well tolerated with only mild toxicities observed.
Takeaway
This study shows that a special type of radiation therapy called carbon ion therapy can help treat a rare kind of cancer in women's reproductive organs, and it seems to work well without causing too many side effects.
Methodology
This is a real-world study involving patients treated with CIRT for unresectable gynecological mucosal melanoma, assessing effectiveness and safety with defined endpoints.
Limitations
The small sample size and short follow-up period limit the statistical strength of the conclusions.
Participant Demographics
All patients were Caucasian, with a median age of 72 years.
Statistical Information
P-Value
0.014
Confidence Interval
95% CI: 0.95–53.6%
Statistical Significance
p = 0.014
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website